The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
800+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
384+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
New
Shop neurotech products
EEG headsets, sleep wearables and brain stimulation devices you can buy today.
Browse by category
View all 800 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
Funding spotlight
Axon Intelligence
Seed — $8M
MindBridge Neuro
Series B — $45M
Neurode Therapeutics
Series A — $22M
iMediSync
Series B
Myomo
Publicly traded (NYSE American: MYO)
Nexalin Technology
Publicly traded (NASDAQ: NXLI)
Latest news
The impossibility of blinding BCI clinical trials poses fundamental methodological challenges that could reshape how the field validates its devices.
New clinical trial data shows implanted brain-computer interfaces successfully restoring expressive communication in paralyzed patients.
Synchron has suspended its brain-computer interface clinical trials after the implanted device failed to perform as expected.
China's BCI sector marks its first year of clinical application, with 12 commercial implants approved and partial reimbursement now available in Shanghai.
Synchron has halted clinical trials of its brain implant following performance issues, marking a significant setback for the BCI sector.
Generative AI techniques are being applied to BCI signal processing, delivering meaningful gains in both accuracy and spatial resolution.
New research shows spiking neural networks can protect BCI signal integrity against severe noise, a persistent barrier to reliable real-world use.
A Chinese brain-computer interface device has achieved 94% mind-typing accuracy sustained across a full day, marking a major milestone for non-invasive BCI.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →You Cannot Blind a Brain-Computer Interface Trial, and That Changes Everything for Clinical Science
The impossibility of blinding BCI clinical trials poses fundamental methodological challenges that could reshape how the field validates its devices.
2026-11-16
Implanted BCIs Restore Expressive Communication for Paralyzed Clinical Trial Participants
New clinical trial data shows implanted brain-computer interfaces successfully restoring expressive communication in paralyzed patients.
2026-11-15
Synchron Halts BCI Trials After Device Falls Short of Performance Benchmarks
Synchron has suspended its brain-computer interface clinical trials after the implanted device failed to perform as expected.
2026-11-14
China's Brain-Computer Interface Sector Enters Clinical Reality With First Commercial Implants
China's BCI sector marks its first year of clinical application, with 12 commercial implants approved and partial reimbursement now available in Shanghai.
2026-11-13
Synchron Pauses Brain Implant Trials After Performance Issues Surface
Synchron has halted clinical trials of its brain implant following performance issues, marking a significant setback for the BCI sector.
2026-11-12
Generative AI Is Closing the Gap on Brain-Computer Interface Accuracy and Resolution
Generative AI techniques are being applied to BCI signal processing, delivering meaningful gains in both accuracy and spatial resolution.
2026-11-11
The field, by the numbers
800+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
128+
Articles
research & industry
Companies by sector
30
Brain-Computer
16
Cognitive
29
Mental
47
Neuromodulation
41
Neuropharmaceuticals
30
Neurodiagnostics
11
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.